bioRxiv Science⌕ Search

Biology subjects

Shemy, A.

Publications and source records attributed to Shemy, A..

2 recordsLinked to original sources

DESPOT: Direction-Enhanced Scoring POTentials

Knowledge-based potentials (KBPs) remain among the most reliable and interpretable scoring functions for protein-ligand interactions, yet most share two structural limitations. They assume that the space around each protein atom is isotropic, and their interaction-conditioned reference state cannot represent regions of space that are preferentially left empty. We introduce DESPOT (Direction-Enhanced Scoring POTentials), an all-atom anisotropic KBP that overcomes both. DESPOT classifies atoms into isotropic, axially symmetric, and fully anisotropic symmetry classes from their hybridization and bonding environment, and discretizes the surrounding interaction space using the according symmetry. By adopting a positionally averaged reference state and using a void ligand atom type, it learns, for every point around a protein atom, the probability that the point is occupied by a given ligand atom type or preferentially left empty - a ligand-independent description that naturally encodes steric exclusion. This occupancy-conditioned potential captures the precise, atom-level placement of ligand atoms; we pair it with a complementary geometry-conditioned, residue-level formulation (DESPOT-screen, in the spirit of KORP-PL) and combine the two inverse-Boltzmann scores into a consensus score, DESPOT-combo. Derived from 110,943 curated, energy-minimized complexes drawn from the CROWN database and evaluated on the CASF-2016 benchmark, DESPOT achieves competitive scoring power (Pearson r = 0.61), while DESPOT-combo attains best-in-class docking power (89.5% top-1 success); all anisotropic DESPOT variants significantly outperform isotropic KBPs and established empirical scoring functions in virtual screening. Anisotropy is decisive for rejecting geometrically implausible poses, and uniting the atom-level precision of DESPOT with the implicit flexibility tolerance of the residue-level score yields the most consistent performance across tasks. Because the same occupancy-conditioned potentials can be evaluated over an empty grid, DESPOT generates molecular interaction fields as well, unifying pose scoring with direction-aware binding-site characterization within a single interpretable model.

bioinformatics↗

Intracellular BAPTA directly inhibits PFKFB3, thereby impeding mTORC1-driven Mcl-1 translation and killing Mcl-1-addicted cancer cells

Intracellular Ca2+ signals control several physiological and pathophysiological processes. The main tool to chelate intracellular Ca2+ is intracellular BAPTA (BAPTAi), usually introduced into cells as a membrane-permeant acetoxymethyl ester (BAPTA-AM). We previously demonstrated that BAPTAi enhanced apoptosis induced by venetoclax, a Bcl-2 antagonist, in diffuse large B-cell lymphoma (DLBCL). These findings implied a novel interplay between intracellular Ca2+ signaling and anti-apoptotic Bcl-2 function. Hence, we set out to identify the underlying mechanisms by which BAPTAi enhances cell death in B-cell cancers. In this study, we observed that BAPTAi alone induced apoptosis in lymphoma cell models that were highly sensitive to S63845, an Mcl-1 antagonist. BAPTAi provoked a rapid decline in Mcl-1 protein levels by inhibiting mTORC1-driven MCL-1 translation. Overexpression of nondegradable Mcl-1 rescued BAPTAi-induced cell death. We further examined how BAPTAi diminished mTORC1 activity and found that BAPTAi impaired glycolysis by directly inhibiting 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) activity, an up to now unkown effect of BAPTAi. All aforementioned effects of BAPTAi were also elicited by a BAPTAi analog with low affinity for Ca2+. Thus, our work reveals PFKFB3 inhibition as an unappreciated Ca2+-independent mechanism by which BAPTAi impairs cellular metabolism and ultimately the survival of Mcl-1-dependent cancer cells. Our work has two important implications. First, direct inhibition of PFKFB3 emerged as a key regulator of mTORC1 activity and a promising target in the treatment of Mcl-1-dependent cancers. Second, cellular effects caused by BAPTAi are not necessarily related to Ca2+ signaling. Our data support the need for a reassessment of the role of Ca2+ in cellular processes when findings were based on the use of BAPTAi.

cell biology↗